Researchers at Mayo Clinic's Center for Individualized Medicine have discovered a rare genetic variant that can directly ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.

Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, an investigational, once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...

Bristol Myers Squibb Co. has synthesized receptor-interacting serine/threonine-protein kinase 1 (RIPK1; RIP-1) inhibitors reported to be useful for the treatment of inflammatory bowel disease, ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of ...

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

Devoid of marketed drugs, investors will focus on VKTX's pipeline updates when it reports first-quarter earnings.

A healthy, well-balanced diet can help ensure healthy liver function and reduce the likelihood of developing liver diseases.

Obesity isn’t just about extra kilos — it’s about how we live and the choices we make every day. The rise in fatty liver ...

The liver, often underappreciated for the complex and critical functions it performs, is now facing new threats from rapidly changing lifestyles, poor dietary habits, increased substance use, and a gr ...

An improper diet can be harmful to liver health, potentially leading to illnesses such as fatty liver disease.